These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Role of WB-MR/DWIBS compared to (18)F-FDG PET/CT in the therapy response assessment of lymphoma. Maggialetti N, Ferrari C, Minoia C, Asabella AN, Ficco M, Loseto G, De Tullio G, de Fazio V, Calabrese A, Guarini A, Rubini G, Brunese L. Radiol Med; 2016 Feb; 121(2):132-43. PubMed ID: 26349573 [Abstract] [Full Text] [Related]
4. Diagnostic performance of 18 fluorodesoxyglucose positron emission/computed tomography and magnetic resonance imaging in detecting T1-T2 head and neck squamous cell carcinoma. Chaput A, Robin P, Podeur F, Ollivier M, Keromnes N, Tissot V, Nonent M, Salaün PY, Rousset J, Abgral R. Laryngoscope; 2018 Feb; 128(2):378-385. PubMed ID: 28600822 [Abstract] [Full Text] [Related]
5. Preoperative staging of non-small-cell lung cancer: comparison of whole-body diffusion-weighted magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography/computed tomography. Sommer G, Wiese M, Winter L, Lenz C, Klarhöfer M, Forrer F, Lardinois D, Bremerich J. Eur Radiol; 2012 Dec; 22(12):2859-67. PubMed ID: 22772365 [Abstract] [Full Text] [Related]
11. Whole-body diffusion-weighted imaging vs. FDG-PET for the detection of non-small-cell lung cancer. How do they measure up? Chen W, Jian W, Li HT, Li C, Zhang YK, Xie B, Zhou DQ, Dai YM, Lin Y, Lu M, Huang XQ, Xu CX, Chen L. Magn Reson Imaging; 2010 Jun; 28(5):613-20. PubMed ID: 20418042 [Abstract] [Full Text] [Related]
20. Diagnostic Value of Whole-Body DWI With Background Body Suppression Plus Calculation of Apparent Diffusion Coefficient at 3 T Versus 18F-FDG PET/CT for Detection of Bone Metastases. Sun W, Li M, Gu Y, Sun Z, Qiu Z, Zhou Y. AJR Am J Roentgenol; 2020 Feb; 214(2):446-454. PubMed ID: 31799866 [Abstract] [Full Text] [Related] Page: [Next] [New Search]